- Student Records
Programme & Unit Catalogues


PA50187: Gastro-intestinal therapeutics

Follow this link for further information on academic years Academic Year: 2018/9
Further information on owning departmentsOwning Department/School: Department of Pharmacy & Pharmacology
Further information on credits Credits: 6      [equivalent to 12 CATS credits]
Further information on notional study hours Notional Study Hours: 120
Further information on unit levels Level: Masters UG & PG (FHEQ level 7)
Further information on teaching periods Period:
Modular (no specific semester)
Further information on unit assessment Assessment Summary: CW 100%
Further information on unit assessment Assessment Detail:
  • Assessment Group A: Medicines Optimisation Tool (ass't grp A) (CW 40%)
  • Assessment Group A: Case Based Discussion (ass't grp A) (CW 20%)
  • Assessment Group A: CARE Tool (ass't grp A) (CW 10%)
  • Assessment Group A: Drug Spend Review (ass't grp A) (CW 30%)
  • Assessment Group B: Medicines Optimisation Tool (ass't grp B) (CW 40%)
  • Assessment Group B: Case Based Discussion (ass't grp B) (CW 20%)
  • Assessment Group B: CARE Tool (ass't grp B) (CW 10%)
  • Assessment Group B: NICE Review (ass't grp B) (CW 30%)
  • Assessment Group C: Medicines Optimisation Tool (ass't grp C) (CW 40%)
  • Assessment Group C: Case Based Discussion (ass't grp C) (CW 20%)
  • Assessment Group C: CARE Tool (ass't grp C) (CW 10%)
  • Assessment Group C: Teaching Session (ass't grp C) (CW 30%)
  • Assessment Group D: Medicines Optimisation Tool (ass't grp D) (CW 40%)
  • Assessment Group D: Case Based Discussion (ass't grp D) (CW 20%)
  • Assessment Group D: CARE Tool (ass't grp D) (CW 10%)
  • Assessment Group D: Designated Alternative ASP (ass't grp D) (CW 30%)
Further information on supplementary assessment Supplementary Assessment:
Like-for-like reassessment (where allowed by programme regulations)
Further information on requisites Requisites:
Further information on descriptions Description: Aims:
To update underpinning pharmacology, physiology and pharmaceutical knowledge in gastro-intestinal disease.

Learning Outcomes:
On successful completion of this unit students will be able to:
1. Describe and analyse the role of the healthcare professional / pharmacist in prescribing, administration and monitoring of medication for patients with gastro-intestinal disease (knowledge and understanding).
2. Explain the disease and patient monitoring factors in this therapeutic area (knowledge and understanding, professional practical skill).
3. Critically evaluate the evidence base for the management of gastro-intestinal disease (intellectual skill).
4. Reflect on their own practice in supporting patients with this diseases and identify areas for continuous improvement (personal transferable skill).
5. Apply the knowledge gained in this unit to design enhancements to patient facing services and the patient experience (professional practical skill; intellectual skill; knowledge and understanding)

Skills:

* Planning & organisation (Taught/Facilitated)
* Study skills (Taught/Facilitated)
* Handling information (Taught/Facilitated)
* Written communication (Taught/Facilitated/Assessed)
* Working with others (Taught/Facilitated)
* Scientific & practical skills (Taught)
* Improving learning & performance T/F/A
* Information & communication technology (ICT) (Taught/Facilitated)
* Problem solving (Taught).

Content:

* Unit Introduction
* Dyspepsia and Peptic Ulcer Disease
* Inflammatory Bowel Disease I
* Inflammatory Bowel Disease II
* Gastro-intestinal Medicine
* Gastro-intestinal Surgery
* Acute Liver Disease
* Chronic Liver Disease
* Drug Induced Liver Disease.
Further information on programme availabilityProgramme availability:

PA50187 is Optional on the following programmes:

Department of Pharmacy & Pharmacology

Notes: